Correlation Between Nascent Biotech and Ceapro
Can any of the company-specific risk be diversified away by investing in both Nascent Biotech and Ceapro at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nascent Biotech and Ceapro into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nascent Biotech and Ceapro Inc, you can compare the effects of market volatilities on Nascent Biotech and Ceapro and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nascent Biotech with a short position of Ceapro. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nascent Biotech and Ceapro.
Diversification Opportunities for Nascent Biotech and Ceapro
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Nascent and Ceapro is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Nascent Biotech and Ceapro Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ceapro Inc and Nascent Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nascent Biotech are associated (or correlated) with Ceapro. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ceapro Inc has no effect on the direction of Nascent Biotech i.e., Nascent Biotech and Ceapro go up and down completely randomly.
Pair Corralation between Nascent Biotech and Ceapro
Given the investment horizon of 90 days Nascent Biotech is expected to generate 6.22 times less return on investment than Ceapro. But when comparing it to its historical volatility, Nascent Biotech is 6.15 times less risky than Ceapro. It trades about 0.05 of its potential returns per unit of risk. Ceapro Inc is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 38.00 in Ceapro Inc on August 31, 2024 and sell it today you would earn a total of 555.00 from holding Ceapro Inc or generate 1460.53% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 77.81% |
| Values | Daily Returns |
Nascent Biotech vs. Ceapro Inc
Performance |
| Timeline |
| Nascent Biotech |
| Ceapro Inc |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Nascent Biotech and Ceapro Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nascent Biotech and Ceapro
The main advantage of trading using opposite Nascent Biotech and Ceapro positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nascent Biotech position performs unexpectedly, Ceapro can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ceapro will offset losses from the drop in Ceapro's long position.| Nascent Biotech vs. Protokinetix | Nascent Biotech vs. Silo Pharma | Nascent Biotech vs. Vg Life Sciences | Nascent Biotech vs. Mymetics Corp |
| Ceapro vs. Biotron Limited | Ceapro vs. biOasis Technologies | Ceapro vs. Covalon Technologies | Ceapro vs. Mosaic Immunoengineering |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |